Evidence map›Paper›PMID 39639813›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Persistence of OXA-48-producing ST-22

Sarah Jolivet, Jeanne Couturier, Killian Le Neindre, Muriel Ehmig, Laurent Dortet, Cécile Emeraud, Frédéric Barbut

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Rising incidence of carbapenem-resistantMicrobiology spectrum · 2026
    Article
  5. Article
  6. Characterization ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah JolivetUnité de prévention du risque infectieux, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
Jeanne CouturierService de microbiologie de l'environnement, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
Killian Le NeindreService de microbiologie de l'environnement, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
Muriel EhmigUnité de prévention du risque infectieux, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.
Laurent DortetAssociated French National Reference Center for Antibiotic Resistance: Carbapenemase-producing Enterobacterales, Le Kremlin-Bicêtre, France.
Cécile EmeraudAssociated French National Reference Center for Antibiotic Resistance: Carbapenemase-producing Enterobacterales, Le Kremlin-Bicêtre, France.
Frédéric BarbutUnité de prévention du risque infectieux, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016-2019, hospital A's haematology ward experienced an outbreak of OXA-48-producing ST-22

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCitrobacter freundiiCross InfectionEnterobacteriaceae InfectionsPhylogenyWhole Genome SequencingDisease OutbreaksFemaleHumansMicrobial Sensitivity TestsPolymorphism, Single NucleotideAnti-Bacterial Agentsbeta-Lactamasesoxacillinasecarbapenemase-producing EnterobacteralesCitrobacter freundiireservoirwater environmentwhole genome sequencing

Identifiers

PMID39639813
PMCPMC11650478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.